Skip to main content
INTT
NASDAQ Industrial Applications And Services

InTest Q3 10-Q Discloses Material Weakness and Revises March 31, 2026 Financials

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Negative
Importance info
8
Price
$13.37
Mkt Cap
$171.481M
52W Low
$7.07
52W High
$20
52W Position info
89% above low
Off High info
33% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

INTT sits 89% above its 52-week low of $7.07.

Summary

InTest's Q3 10-Q repeats the morning's $35.1M revenue and $0.15 EPS but newly discloses a material weakness in inventory controls at Alfamation and a revision of its March 31, 2026 financials that cut Q1 EPS to $0.01 from $0.06.


Key Events · Earnings and Guidance · INTT

  • Material Weakness Disclosed

    Controls over inventory reporting at Alfamation were not appropriately designed after a new ERP system went live in early 2026; the CEO and CFO concluded disclosure controls and procedures were not effective at September 30, 2026.

  • March 31, 2026 Financials Revised

    Inventory was overstated and cost of revenue understated by $750K, cutting Q1 net earnings by $606K and Q1 EPS from $0.06 to $0.01; the company judged the errors immaterial to the original filing but material if booked solely in Q2.

  • Q3 Results Match Morning 8-K

    Revenue of $35.1M versus $26.2M a year ago, net earnings of $1.9M and EPS of $0.15 versus a $0.08 loss; gross margin rose to 47.7% from 41.9%.

  • Backlog and Cash Build

    Backlog was $59.7M at September 30, 2026 versus $49.3M a year earlier and $53.9M at December 31, 2025; cash and cash equivalents rose to $20.9M from $14.2M at year-end.


Analysis · INTT · Industrial Applications And Services

The headline numbers match this morning's 8-K — Q3 revenue of $35.1M and EPS of $0.15 — but the 10-Q carries what the press release did not: a material weakness in internal control over financial reporting and a revision of previously issued March 31, 2026 interim statements. Controls over inventory reporting at Alfamation were not properly designed after a new ERP system went live in early 2026, overstating ending inventory and understating cost of revenue by $750K; the correction cut Q1 net earnings by $606K and Q1 EPS from $0.06 to $0.01. Management and the CEO/CFO concluded disclosure controls were not effective at September 30, 2026, and remediation is not expected to be demonstrably complete until fiscal year-end. That is a governance problem layered on an otherwise strong quarter — gross margin of 47.7% versus 41.9% a year ago and backlog of $59.7M versus $49.3M — and it is the kind of disclosure that can pressure the stock independent of the operating results.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, INTT was trading at $13.37 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $171.5M. The 52-week trading range was $7.07 to $20.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INTT - Latest Insights

INTT
Nov 06, 2026, 7:20 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.71
Real-time Price: $10.92 info
Change: -$1.79 (-14%) info
Market Cap: $140.299M info